Curian Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-56,926
Closed -$5.85M 204
2015
Q4
$5.85M Sell
56,926
-110,499
-66% -$11.1M 0.43% 42
2015
Q3
$15.6M Sell
167,425
-94,472
-36% -$9.14M 0.42% 43
2015
Q2
$25.5M Buy
261,897
+7,301
+3% +$731K 0.43% 44
2015
Q1
$25.6M Sell
254,596
-72,365
-22% -$7.36M 0.43% 45
2014
Q4
$34.2M Buy
326,961
+14,945
+5% +$1.57M 0.58% 36
2014
Q3
$33.3M Buy
312,016
+10,766
+4% +$1.12M 0.59% 30
2014
Q2
$31.5M Buy
301,250
+51,568
+21% +$5.21M 0.55% 34
2014
Q1
$24.5M Buy
249,682
+44,642
+22% +$4.14M 0.44% 41
2013
Q4
$18.8M Buy
205,040
+2,076
+1% +$191K 0.33% 54
2013
Q3
$17.6M Buy
202,964
+7,293
+4% +$654K 0.31% 50
2013
Q2
$16.8M Buy
+195,671
New +$16.6M 0.3% 50

Other funds holding JNJ

Curian Capital's JNJ Position: Q1 2016 in Review

Curian Capital sold out of Johnson & Johnson (JNJ) in Q1 2016, closing a stake of 56,926 shares — an estimated $5.85M sold.

Curian Capital first reported a position in JNJ in Q2 2013 and held it in 11 quarters. The position peaked at $34.2M in Q4 2014. 2,203 funds tracked by Wall St. Rank hold JNJ as of Q1 2016.

  • Curian Capital reported no remaining Johnson & Johnson position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 56,926 Johnson & Johnson shares in Q1 2016, an estimated $5.85M.
  • Curian Capital first reported a position in Johnson & Johnson in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Johnson & Johnson position peaked at $34.2M in Q4 2014.
  • 2,203 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.